NotesFAQContact Us
Search Tips
Back to results
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ1028779
Record Type: Journal
Publication Date: 2014-Jul
Pages: 3
Abstractor: As Provided
ISSN: ISSN-0017-8969
Aspirin Risks in Perspective: A Comparison against Marathon Running
Morgan, Gareth
Health Education Journal, v73 n4 p491-493 Jul 2014
Aspirin has public health potential to reduce the risk of ischaemic vascular events and sporadic cancer. One objection to the wider use of aspirin for primary prevention, however, is the undesirable effects of the medicine, which include increasing risk of bleeding and haemorrhagic stroke. Marathons also carry risks of serious events such as cardiac arrests and sudden death. Based on epidemiological estimates, a person running a marathon might be 20 to 100 times more likely to end up in hospital than a person who is taking an aspirin tablet. Yet the cumulative risk of daily aspirin use for primary prophylaxis may be important. One option open to middle-aged individuals who want to take aspirin is to start with an infrequent regime, such as once per week, in order to then build to daily use. It is important to get all concerns into perspective and comparisons can offer a challenge to any excessive risk aversion regarding the public health potential of aspirin.
SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail:; Web site:
Publication Type: Journal Articles; Reports - Descriptive
Education Level: N/A
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: N/A